Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$29.52 -0.32 (-1.07%)
At close: Sep 29, 2026 · 4:00 PM EDT

Lakefront Biotherapeutics (LKFT) EV to EBITDA (2017)

Updated

Lakefront Biotherapeutics' (LKFT) EV to EBITDA came in at 16.53 for the year ended Dec 31, 2019.

Analysis

Lakefront Biotherapeutics (LKFT) EV to EBITDA (2017) Analysis & Trends

  • The figure for the year ended Dec 31, 2019 stands as the lowest annual EV to EBITDA since the year ended Dec 31, 2016.
  • Business Quant data shows LKFT's EV to EBITDA at 1.96 in the year ended Dec 31, 2016 (+289.5%) and 0.50 in the year ended Dec 31, 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Lakefront Biotherapeutics 1.97 Bn 1.97 Bn 3.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 0.93
API Access

Lakefront Biotherapeutics EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=LKFT&period=max&api_key=YOUR_API_KEY